Published in Prog Brain Res on January 01, 1983
Pyramidal neurons in rat prefrontal cortex projecting to ventral tegmental area and dorsal raphe nucleus express 5-HT2A receptors. Cereb Cortex (2008) 0.98
Tonic and phasic release of glutamate and acetylcholine neurotransmission in sub-regions of the rat prefrontal cortex using enzyme-based microelectrode arrays. J Neurosci Methods (2011) 0.90
The absence of 5-HT(1A) receptors has minor effects on dopamine but not serotonin release evoked by MK-801 in mice prefrontal cortex. Psychopharmacology (Berl) (2008) 0.77
Laminar and Cellular Distribution of Monoamine Receptors in Rat Medial Prefrontal Cortex. Front Neuroanat (2017) 0.75
Regional studies of catecholamines in the rat brain. I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain. J Neurochem (1966) 7.91
Hippocampo-prefrontal cortex pathway: anatomical and electrophysiological characteristics. Hippocampus (2000) 2.18
Spinal tuberculosis in adults. A study of 103 cases in a developed country, 1980-1994. Medicine (Baltimore) (1999) 2.11
The physiologic disposition and metabolism of norepinephrine in immunosympathectomized animals. J Pharmacol Exp Ther (1966) 2.03
Disinhibition as a basic process in the expression of striatal functions. Trends Neurosci (1990) 1.94
Reduced uptake of tritiated noradrenaline in tissues of immunosympathectomized animals. Nature (1965) 1.91
Inhibition by anandamide of gap junctions and intercellular calcium signalling in striatal astrocytes. Nature (1995) 1.83
Enterocytic differentiation of a subpopulation of the human colon tumor cell line HT-29 selected for growth in sugar-free medium and its inhibition by glucose. J Cell Physiol (1985) 1.82
Dopaminergic terminals in the rat cortex. Science (1973) 1.73
Pyruvate protects neurons against hydrogen peroxide-induced toxicity. J Neurosci (1997) 1.66
G(olf) and Gs in rat basal ganglia: possible involvement of G(olf) in the coupling of dopamine D1 receptor with adenylyl cyclase. J Neurosci (1993) 1.66
Identification of presynaptic serotonin autoreceptors using a new ligand: 3H-PAT. Nature (1983) 1.66
Mechanism involved in initiation and propagation of receptor-induced intercellular calcium signaling in cultured rat astrocytes. J Neurosci (1997) 1.62
Dendritic release of dopamine in the substantia nigra. Nature (1981) 1.58
Uptake, storage and metabolism of norepinephrine in tissues of the developing rat. J Pharmacol Exp Ther (1967) 1.58
Selective activation of mesocortical DA system by stress. Nature (1976) 1.56
Knock-out of the neural death effector domain protein PEA-15 demonstrates that its expression protects astrocytes from TNFalpha-induced apoptosis. J Neurosci (1999) 1.52
Astrocytes protect neurons from hydrogen peroxide toxicity. J Neurosci (1996) 1.51
Nicotine protects cultured striatal neurones against N-methyl-D-aspartate receptor-mediated neurotoxicity. Neuroreport (1994) 1.46
Stimulation of dopamine release by GABA in rat striatal slices. Brain Res (1978) 1.45
Effect of noxious tail pinch on the discharge rate of mesocortical and mesolimbic dopamine neurons: selective activation of the mesocortical system. Brain Res (1989) 1.45
Importance of the noradrenaline-dopamine coupling in the locomotor activating effects of D-amphetamine. J Neurosci (1998) 1.44
Characterization of PEA-15, a major substrate for protein kinase C in astrocytes. J Biol Chem (1993) 1.43
In vivo activity-dependent plasticity at cortico-striatal connections: evidence for physiological long-term potentiation. Proc Natl Acad Sci U S A (1997) 1.40
Gap junctions in cultured astrocytes: single-channel currents and characterization of channel-forming protein. Neuron (1991) 1.40
Inhibition by hemicholinium-3 of (14C)acetylcholine synthesis and (3H)choline high-affinity uptake in rat striatal synaptosomes. Mol Pharmacol (1973) 1.36
Relationships between the prefrontal cortex and the basal ganglia in the rat: physiology of the corticosubthalamic circuits. J Neurosci (1998) 1.36
Effects of stress on the metabolism of norepinephrine, dopamine and serotonin in the central nervous system of the rat. I. Modifications of norepinephrine turnover. J Pharmacol Exp Ther (1968) 1.33
Selectivity of the hippocampal projection to the prelimbic area of the prefrontal cortex in the rat. Brain Res (1989) 1.32
Intracellular recordings in thalamic neurones during spontaneous spike and wave discharges in rats with absence epilepsy. J Physiol (1998) 1.32
Enterocytic differentiation and glucose utilization in the human colon tumor cell line Caco-2: modulation by forskolin. J Cell Physiol (1985) 1.30
Relationship between EEG potentials and intracellular activity of striatal and cortico-striatal neurons: an in vivo study under different anesthetics. Cereb Cortex (2001) 1.30
The uptake and storage of H3-norepinephrine in the reserpine-pretreated rat heart. J Pharmacol Exp Ther (1965) 1.30
Anatomical and electrophysiological evidence for a direct projection from Ammon's horn to the medial prefrontal cortex in the rat. Exp Brain Res (1987) 1.29
Some evidence for the existence of dopaminergic neurons in the rat cortex. Brain Res (1973) 1.26
Nicotinic receptors in the rat prefrontal cortex: increase in glutamate release and facilitation of mediodorsal thalamo-cortical transmission. Eur J Neurosci (1999) 1.25
Rapid molecular typing of Tuber melanosporum, T. brumale and T. indicum from tree seedlings and canned truffles. Anal Bioanal Chem (2004) 1.23
A sustained effect of electroconvulsive shock on the turnover of norepinephrine in the central nervous system of the rat. Proc Natl Acad Sci U S A (1967) 1.23
Regional studies of catecholamines in the rat brain. II. Rate of turnover of catecholamines in various brain regions. J Neurochem (1966) 1.23
Inhibitory influence of the mesocortical dopaminergic system on spontaneous activity or excitatory response induced from the thalamic mediodorsal nucleus in the rat medial prefrontal cortex. Brain Res (1984) 1.23
The intracellular accumulation of UDP-N-acetylhexosamines is concomitant with the inability of human colon cancer cells to differentiate. J Biol Chem (1985) 1.22
Possible existence of a new tachykinin receptor subtype in the guinea pig ileum. Peptides (1992) 1.21
In vivo induction of striatal long-term potentiation by low-frequency stimulation of the cerebral cortex. Neuroscience (1999) 1.21
Vasoactive intestinal peptide: a potent stimulator of adenosine 3':5'-cyclic monophosphate accumulation in gut carcinoma cell lines in culture. Proc Natl Acad Sci U S A (1978) 1.21
Adult corneal epithelium basal cells possess the capacity to activate epidermal, pilosebaceous and sweat gland genetic programs in response to embryonic dermal stimuli. Development (2000) 1.20
Glial heterogeneity may define the three-dimensional shape of mouse mesencephalic dopaminergic neurones. Nature (1984) 1.20
Differential effects of ascending neurons containing dopamine and noradrenaline in the control of spontaneous activity and of evoked responses in the rat prefrontal cortex. Neuroscience (1988) 1.19
Glutamate-dependent phosphorylation of elongation factor-2 and inhibition of protein synthesis in neurons. J Neurosci (1997) 1.19
Hyperactivity of remaining dopaminergic neurones after partial destruction of the nigro-striatal dopaminergic system in the rat. Nat New Biol (1973) 1.19
Regional studies of catecholamines in the rat brain. IV. Effects of drugs on the disposition and metabolism of H3-norepinephrine and H3-dopamine. J Pharmacol Exp Ther (1966) 1.18
Disinhibition as a basic process in the expression of striatal functions. II. The striato-nigral influence on thalamocortical cells of the ventromedial thalamic nucleus. Brain Res (1985) 1.17
Selective activation of the mesocortico-frontal dopaminergic neurons induced by lesion of the habenula in the rat. Brain Res (1980) 1.16
Long-term potentiation in the prefrontal cortex following stimulation of the hippocampal CA1/subicular region. Neurosci Lett (1990) 1.16
Sequence of the complete cDNA and the 5' structure of the human sucrase-isomaltase gene. Possible homology with a yeast glucoamylase. Biochem J (1992) 1.14
Cellular expression, developmental regulation, and phylogenic conservation of PEA-15, the astrocytic major phosphoprotein and protein kinase C substrate. J Neurochem (1995) 1.13
Nicotinic effect of acetylcholine on the release of newly synthesized (3H)dopamine in rat striatal slices and cat caudate nucleus. Brain Res (1976) 1.13
Endothelin induces a calcium-dependent phosphorylation of PEA-15 in intact astrocytes: identification of Ser104 and Ser116 phosphorylated, respectively, by protein kinase C and calcium/calmodulin kinase II in vitro. J Neurochem (1998) 1.13
Relationship between the locomotor hyperactivity induced by A10 lesions and the destruction of the fronto-cortical dopaminergic innervation in the rat. Brain Res (1978) 1.13
Characteristics of central 5-HT receptors and their adaptive changes following intracerebral 5,7-dihydroxytryptamine administration in the rat. Mol Pharmacol (1978) 1.11
Segregation and convergence of information flow through the cortico-subthalamic pathways. J Neurosci (2001) 1.11
Regulation of nov by WT1: a potential role for nov in nephrogenesis. Oncogene (1996) 1.10
Effect of striatal cells on in vitro maturation of mesencephalic dopaminergic neurones grown in serum-free conditions. Nature (1980) 1.09
Activity-dependent neuronal control of gap-junctional communication in astrocytes. J Cell Biol (2000) 1.09
Inhibitory effects of ventral tegmental area stimulation on the activity of prefrontal cortical neurons: evidence for the involvement of both dopaminergic and GABAergic components. Neuroscience (1992) 1.09
Blockade of prefronto-cortical alpha 1-adrenergic receptors prevents locomotor hyperactivity induced by subcortical D-amphetamine injection. Eur J Neurosci (1994) 1.08
Involvement of cholinergic presynaptic receptors of nicotinic and muscarinic types in the control of the spontaneous release of dopamine from striatal dopaminergic terminals in the rat. J Pharmacol Exp Ther (1977) 1.08
Cortical inputs to the subthalamus: intracellular analysis. Brain Res (1981) 1.08
Phenotypic expression of histocompatibility antigens in human primary tumours and metastases. Clin Exp Metastasis (1989) 1.08
Dopamine-norepinephrine: another regulatory step of norepinephrine synthesis in central noradrenergic neurons. Eur J Pharmacol (1971) 1.07
Acetylcholine synthesis from (2- 14 C)pyruvate in rat striatal slices. J Neurochem (1973) 1.06
Inhibition of dopamine release in the cat caudate nucleus by nigral application of glycine. Eur J Pharmacol (1978) 1.05
In vitro maturation of mesencephalic dopaminergic neurons from mouse embryos is enhanced in presence of their striatal target cells. Proc Natl Acad Sci U S A (1979) 1.05
Disinhibition as a basic process in the expression of striatal functions. I. The striato-nigral influence on tecto-spinal/tecto-diencephalic neurons. Brain Res (1985) 1.05
A new type of tachykinin binding site in the rat brain characterized by specific binding of a labeled eledoisin derivative. Mol Pharmacol (1984) 1.04
Effects of drugs on the disposition of H-3-norepinephrine in the rat brain. Pharmacol Rev (1966) 1.04
Glutamatergic control of dopamine release in the rat striatum: evidence for presynaptic N-methyl-D-aspartate receptors on dopaminergic nerve terminals. J Neurochem (1991) 1.04
Increase in external glutamate and NMDA receptor activation contribute to H2O2-induced neuronal apoptosis. J Neurochem (1999) 1.02
Release of newly synthesized dopamine from dopamine-containing terminals in the striatum of the rat. Proc Natl Acad Sci U S A (1969) 1.02
[Epidemiological aspects of osteoarticular tuberculosis in adults. Retrospective study of 206 cases diagnosed in the Paris area from 1980 to 1994]. Presse Med (1997) 1.02